WORLDWIDE CONTACT US ABOUT US PRODUCTS RESEARCH LICENSING NEWSROOM CAREERS INVESTORS Menu MENU It's Personal LIVING WITH HIV “I’m sorry to tell you this … you’ve tested positive for HIV.” The year was 1995, but Merck HIV Community Liaison Catherine Elliott remembers that scene as though it happened yesterday. “When I first found out I was HIV positive, I was scared. I was shocked.” But rather than letting the disease defeat her, Catherine immersed herself in learning more about it. “As a result of educating myself about HIV disease, I found that I had a passion for helping others also.” THIS IS CATHERINE’S STORY 2014 HIV STATS WORLDWIDE Approximately 36.9 MILLION people were living with HIV at the end of 2014 Approximately 2 MILLION people became newly infected with HIV in 2014 It is estimated that currently only 51% of people with HIV know their status. Source: World Health Organization Copyright © 2009-2016 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. Forward-Looking Statement Privacy Terms of Use Site Map

WORLDWIDE CONTACT US ABOUT US PRODUCTS RESEARCH LICENSING NEWSROOM CAREERS INVESTORS Menu MENU OUR WORK IN HEPATITIS C Globally, an estimated 170 million people are living with chronic hepatitis C infection. Most don't know it. CHRONIC HEPATITIS C IS A SERIOUS LIVER DISEASE CAUSED BY THE HEPATITIS C VIRUS (HCV) THAT, OVER TIME, CAN CAUSE LIVER DAMAGE AND CIRRHOSIS (SCARRING OF THE LIVER). IN THE U.S. 3.5 MILLION adults in the U.S. 75% are people born from 1945 to 1965. Approximately 3.5 million adults in the U.S. have chronic HCV infection. More than 75 percent of them are people born from 1945 to 1965. For nearly 30 years, Merck has been at the forefront of the response to chronic HCV, and our team continues to work tirelessly to advance scientific knowledge of this significant global public health issue. IN THE PAST DECADE, MERCK'S CLINICAL DEVELOPMENT PROGRAMS IN CHRONIC HCV INFECTION HAVE: Enrolled Approximately 10,000 Participants Included more than 135 Clinical Trials in Approximately 40 Countries WHAT IT TAKES TO INNOVATE Drs. Eirum Chaudhri and Eliav Barr have worked together at Merck for many years in drug discovery. Learn more about why they find working on chronic hepatitis C so exciting, and what it takes to innovate. READ MORE FROM ELIAV AND EIRUM. RESOURCES Hepatitis C: A Medical - and Social - Diagnosis The Fight Against Hepatitis C Hepatitis C: A Silent Disease and Growing Concern Hepatitis C Infographic Copyright © 2009-2016 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. Forward-Looking Statement Privacy Terms of Use Site Map